Search is Powered by Google
Cancer / Oncology News

Health Services Research Finds Specialty Hospitals Not More Cost-Efficient Than Full-Service Hospitals

Main Category: Cancer / Oncology
Also Included In: Cardiovascular / Cardiology;  Public Health
Article Date: 03 Oct 2008 - 6:00 PST

email icon email to a friend   printer icon printer friendly   write icon view / write opinions   rate icon rate article


Current Article Ratings:

Patient / Public:1 star

1 (1 votes)

Health Professional:not yet rated

Article Opinions: 1 posts

One of the most notable recent developments in the U.S. hospital industry is the rapid rise of small hospitals specializing in cardiac, orthopedic, or surgical services which have tripled in number over the past 15 years. A new study in Health Services Research compared the costs of physician-owned specialty hospitals with those of full-service hospitals. Results show that specialty hospitals are not more cost-efficient than the full-service hospitals with whom they compete.

Results show that orthopedic and surgical specialty hospitals appear to have significantly higher levels of cost inefficiency. This effect was not observed among cardiac specialty hospitals.

"We do conclude from our analysis that policy makers should not adopt the assumption that physician-owned specialty hospitals produce patient care more efficiently than their full-service competitors," the authors note.

Kathleen Carey, James F. Burgess Jr., and Gary J. Young analyzed hospital costs using inpatient data from three states where single specialty hospitals are highly prevalent, includingTexas, California, and Arizona.

----------------------------
Article adapted by Medical News Today from original press release.
----------------------------

This study is published in the October 2008 issue of Health Services Research.

To view the abstract for this article, please click here.

Kathleen Carey is affiliated with Boston University School of Public Health.

Health Services Research (HSR) provides those engaged in research, public policy formulation, and health services management with the latest findings, methods, and thinking on important policy and practice issues. An outlet for the publication of the latest and best research on financing, organization, delivery, and outcomes of health services, HSR allows practitioners and students alike to exchange ideas that will help to improve the health of individuals and communities.

Source: Amy Molnar
Wiley-Blackwell




Personalized Homepage Weekly Newsletters Daily News Alerts
Opioid Induced Constipation ADHD Anxiety Asthma Autism Cancer Diabetes Lung Cancer Lupus Medicare / Medicaid Obesity and BMI Pancreatic Cancer Stem Cells All 'What Is...' Articles All 'How To...' Articles

Ophthalmology Urology
About Us News Licensing Free Website Feeds Free Tools & Content Tell a Friend Accessibility Help / FAQ Article Submission Links Contact Us

add medical news today to your facebook
medical news gadget

Swine Flu Image

Swine Flu Updates

- Latest Swine Flu News
- What is Swine Flu?
- Map Of H1N1 Outbreaks
- Swine Flu - Top 20 FAQ
- Daily Email News Alerts
Stick with Medical News Today for the latest news updates on swine flu.


These are the most read articles from this news category for the last 6 months:
Top Article Star
Understanding And Treating Triple-Negative Breast Cancer
07 Jan 2009
Triple-negative breast cancer is a subtype of breast cancer that is clinically negative for expression of estrogen and progesterone receptors (ER/PR) and HER2 protein. It is characterized by its unique molecular profile...


Monitoring and Adherence in CML image Monitoring and Adherence in CML

Imatinib, or Gleevec, is a targeted anti-cancer drug that can keep chronic myelogenous leukemia (CML) in check for most patients for many years. It is important for patients to take imatinib as prescribed by their doctor to fight the disease and to guard against resistance...

Treating HER2+ Breast Cancer image Treating HER2+ Breast Cancer

There are at least four different kinds of breast cancer and each is treated differently. For HER2+ breast cancer, a chemotherapy drug is typically the best option. Here's an overview of the drugs used to treat breast cancer...

View more videos...